Daysi Diaz-Diestra

Dr. Diaz-Diestra obtained her PhD in Physical Chemistry in 2019 from the University of Puerto Rico-Rio Piedras. Her doctoral research focused on the development of sensing and drug delivery platforms based on functional engineered nanomaterials, and their potential toxic effects on in vitro settings. After graduation, she joined the FDA Center for Devices and Radiological Health as an ORISE postdoctoral research fellow. Her research focused on regulatory control and biocompatibility assessment of nanoformulations used in medical devices.  She joined the CCNTP in December 2020, where she is working under the guidance of Drs. Jenny Ting and Leaf Huang in Nanoparticle-Enabled Cancer Immunotherapy